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Abstract
Purpose—To compare three preference-based health-related quality-of-life (HRQL) measures
and examine independent correlates of HRQL among overweight and obese women with urinary
incontinence (UI) enrolled in a weight loss intervention trial.
Methods—Participants completed baseline questionnaires, which included the Health Utilities
Index 3 (HUI3) and Medical Outcomes Study Short Form-36 (SF-36). The SF-36 was used to
derive SF-6D and estimated Quality of Well-Being (eQWB) scores. Height, weight, medical
history, incontinence measures, and level of physical activity also were assessed. The intraclass
correlation coefficient (ICC) was computed, and differences in mean scores across HRQL
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measures were examined. Potential correlates of HUI3, SF-6D, and eQWB scores were evaluated
using multivariable generalized linear models.
Results—Mean ± SD scores for the HUI3, SF-6D, and eQWB were 0.81 ± 0.18, 0.75 ± 0.10, and
0.71 ± 0.06, respectively. Significant differences were observed across measures (P < 0.0001), and
the overall ICC was 0.36. In multivariable analyses, BMI was negatively associated with HUI3 (P
= 0.003) and eQWB (P < 0.001), and UI episode frequency was negatively associated with eQWB
(P = 0.015) and SF-6D (P < 0.001).
Conclusions—Significant differences in mean utilities across the HUI3, SF-6D, and eQWB
indicate that these measures do not assess identical dimensions of HRQL. Both BMI and UI
episode frequency were related to HRQL in this cohort; however, the magnitude of the
relationship depended on the preference-based measure used. These findings highlight the need to
consider the method used to generate HRQL values for calculating quality-adjusted life-years in
cost-utility analyses, since choice of method may have a substantial impact on the outcome of the
analysis.
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Introduction
Both urinary incontinence (UI) and obesity are common conditions that have a significant
impact on health [1-4], and observational studies suggest that obesity is a strong risk factor
for UI [5, 6]. While numerous studies have shown that obesity and UI have negative effects
on health-related quality of life (HRQL) [2, 7-22], fewer studies [2,9, 13, 15, 18-20, 22]
have assessed HRQL with preference-based methods that can be used to incorporate the
quality-of-life effects of these conditions into economic analyses of interventions aimed at
reducing UI and obesity.
Unlike non-preference-based measures of HRQL that assign scores based on the level of
functioning in various domains of health assessed, preference-based measures incorporate
how patients (or members of the general public) value experiencing a given health state (or a
hypothetical health state) that is defined by levels of functioning and well-being in these
domains. These scores can be combined with life expectancy estimates to calculate quality-
adjusted life-years (QALYs) for use in cost-utility analyses (CUAs) [23]. Several
preference-based HRQL measures have been developed, including the Health Utilities Index
(HUI) [24, 25], Quality of Well-Being scale (QWB) [26-28], Short Form 6D (SF-6D) [29,
30], and EuroQol 5D (EQ5D) [31, 32]. Each is based on different dimensions, items, and
preference weights, which typically yield diverging utility scores for currently experienced
health states. Variability in the estimates obtained from different measures may complicate
comparisons of the cost effectiveness of interventions. To better understand potential
differences in preference-based HRQL estimates and further inform the selection of
measures to be used in economic analyses, comparative studies of these measures have been
recommended [33].
The purpose of the current study was to compare three preference-based HRQL measures
and examine independent correlates of HRQL among overweight and obese women with
urinary incontinence (UI) enrolled in a weight loss intervention trial. We used HUI3 and
Medical Outcomes Study Short Form-36 (SF-36) data collected in this cohort to generate the
following preference-based HRQL scores: HUI3, SF-6D, and estimated QWB (eQWB).
Correlates of these scores were also examined.
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Participants (N = 338) were recruited between July 2004 and April 2006 in Providence,
Rhode Island and Birmingham, Alabama and enrolled in the Program to Reduce
Incontinence by Diet and Exercise (PRIDE) randomized clinical trial. Characteristics of the
study sample and inclusion and exclusion criteria have been previously reported [34].
Women who were at least 30 years of age and had a BMI of 25–50 kg/m2 and reported 10 or
more urinary incontinence episodes on a 7-day voiding diary at baseline were eligible for the
study. Exclusion criteria included the use of medical therapy for incontinence or weight loss
within the prior month, current urinary tract infection, major medical or genitourinary tract
conditions, pregnancy or having given birth in the previous 6 months, type 1 or type 2
diabetes requiring medical therapy that increases the risk of hypoglycemia, and uncontrolled
hypertension. The study was approved by the institutional review board at each site, and
written informed consent was obtained from all participants before enrollment.
Study design
The PRIDE study was an 18-month two-site clinical trial to determine whether a behavioral
weight reduction intervention for overweight and obese women with incontinence results in
greater reductions in frequency of incontinence episodes at 6- and 18-months compared with
a control group. Eligible participants were randomly allocated to a 6-month intensive
behavioral weight loss program (intervention; n = 226) followed by a 12-month weight
maintenance program or to a structured education program (control; n = 112). The current
investigation is a cross-sectional analysis of the preference-based measures of HRQL
collected at baseline (prior to randomization) including all participants.
Measures
Demographic characteristics and medical, behavioral, and incontinence histories were
ascertained using self-report questionnaires. Body weight was measured in street clothes
with shoes removed, using a calibrated digital scale (Tanita BWB 800) and recorded to the
nearest 0.5 kg. Height was measured at baseline to the nearest centimeter using a calibrated
wall-mounted stadiometer and a horizontal measuring block. Body mass index (BMI) was
calculated as weight in kg/height in meters squared (kg/m2).
Participants completed a 7-day voiding diary in which they recorded each incontinence
episode, identified by the participant as stress (involuntary loss of urine with coughing,
sneezing, straining, or exercise), urge (loss of urine associated with a strong need or urge to
void), or other, based on the instructions provided. Incontinence type was then classified as
stress only; stress predominant (stress episodes comprised at least 2/3 of the total); urge
only; urge predominant (urge episodes comprised at least2/3 of the total); or mixed
incontinence (at least two types were reported but no type comprised at least 2/3 of the
total). The quantity of urine lost involuntarily was measured using a standardized pad test
[34]. Participants collected and returned in sealed plastic bags pre-weighed urinary
incontinence pads used during a 24-h period, and the post-test weight of each pad was
recorded.
Physical activity was assessed by self-report using the Paffenbarger Activity Questionnaire
[35], which estimates calorie expenditure in overall leisure activity (e.g., number of stairs
climbed, number of blocks walked) and in light (5 kcal/min), medium (7.5 kcal/min), and
high (10 kcal/min) intensity physical activity.
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Health-related quality of life was measured using the HUI3 and the SF-36. The HUI3 [24,
25] is a 15-item generic, participant-completed measure of health status, and HRQL that has
been used in both clinical and population health studies. The HUI3 includes items assessing
eight attributes: vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain.
Each attribute has 5–6 levels of functioning, describing 972,000 unique health states. These
data are converted into a multiattribute utility score using community-based preference
weights that reflects global HRQL on a scale of −0.36 to 1.0, where −0.36 is the worst
possible state, 0 is equal to dead, and 1.0 is equal to perfect or ideal health. A difference of
0.03 or greater on the overall HUI3 score is clinically important [19, 36-38]. The SF-36 [39,
40] is a 36-item generic self-report survey that assesses health across eight dimensions
(physical functioning, role limitations-physical, bodily pain, general health, vitality, social
functioning, role limitations-emotional, and mental health). It has been widely used to assess
general health status in population studies, estimate disease burden, and examine health
outcomes in clinical research trials of numerous conditions [40].
The SF-36 was used to generate two scores: an SF-6D score [29] and an estimated QWB
score, referred to as the eQWB [41, 42]. The SF-6D score was derived from 11 questions on
the SF-36 that include six health dimensions (physical functioning, role limitations, social
functioning, pain, mental health, and vitality) and defines 18,000 health states. Developed in
the UK general population, SF-6D scores range from 0.30 to 1.00 (where 1.00 indicates “full
health”). For the SF-6D, the mean minimal important difference has been reported as 0.03–
0.04 [43, 44]. The eQWB score was derived using the regression equation from Fryback and
colleagues [42] based on data from a community-based population study (Beaver Dam
Health Outcomes Study) and includes five health dimensions (physical functioning, mental
health, bodily pain, general health perceptions, and role limitations-physical). This
derivation has been used in prior studies [41, 45]. The bounds of the eQWB based on this
equation are 0.45–0.84. We did not find published reports of the minimal important
difference for the eQWB; however, the minimal important difference for the QWB has been
reported as 0.03 [46].
Statistical analyses
Multivariable generalized linear models were developed to identify potential correlates of
HUI3, SF-6D, and eQWB scores. To meet normality assumptions, the HUI3 was log-
transformed; UI frequency, an independent variable in the models, was likewise log-
transformed to meet linearity assumptions. Variables with P values <0.20 in univariable
(i.e., single-predictor) analyses were considered for inclusion in the multivariable (i.e.,
multi-predictor) models. These variables included educational level, annual household
income (<$40,000, $40,000–$99,999, ≥$100,000), BMI, menopausal status, prior
hysterectomy, prior pelvic organ prolapse surgery, number of live births, current smoking,
ever smoked 100 cigarettes, UI episode frequency, monthly or greater fecal incontinence,
and kilocalories expended per day through physical activity (quartiles: 0–112, 140–364,
392–1,078, 1,092–7,841). Relationship status (married/partnered, single/widowed/divorced),
alcohol use, UI type (stress, urge, mixed), and 24-h involuntary urine loss on pad test had P
values > 0.20 in univariable analyses and thus were not included in multivariable models.
Age, race (white/non-white), and clinical site (Providence/Birmingham) were included in all
models. The final model for each endpoint was chosen by backward elimination of variables
with P values > 0.20. Effect size [47] was assessed using the η2 statistic, which indicates the
proportion of variance explained by each variable independently in a multivariable model.
To examine degree of agreement among HRQL measures, the intraclass correlation
coefficient (ICC) was computed using the between-subject and error mean squares from a
two-way analysis of variance with random participant and fixed instrument effects; this is
case 3,1 in Shrout and Fleiss’s framework [48]. In addition, we assessed differences in mean
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response levels on the three instruments using a repeated measures model with unstructured
residual covariance matrix. In this analysis, untransformed HUI-3 scores were used. Finally,
we used a repeated measures model with appropriate interactions to determine whether
covariates were differentially associated with the three instruments. In this analysis, we
standardized each instrument score to have unit variance.
Multiple imputation was used for missing data, in particular for household income (21% not
reported or missing) and post-menopausal status (6% missing). Twenty imputed data sets
were made, with results combined using standard techniques for multiply-imputed data, as
implemented in SAS Proc MI and Proc MIAnalyze. A P value of<0.05 was considered
statistically significant. All analyses were implemented in SAS Version 9.2 (SAS Institute,
Cary, NC).
Results
Mean ± standard deviation (SD) age for participants was 53 ± 11 years. Nineteen percent of
these women were African American and 45% reported their health to be “excellent” or
“very good”. They had a mean BMI of 36 ± 6 kg/m2 and a mean weight of 97 ± 17 kg
(Table 1). The average number of total weekly incontinence episodes was 24 ± 18; 22% of
the participants were classified as having stress only or stress predominant UI, 44% urge
only or urge predominant UI, and 34% mixed UI.
Means ± SD on the HUI3, SF-6D, and eQWB were 0.81 ± 0.18 (range = 0.08–1.00), 0.75 ±
0.10 (range = 0.47–0.97), and 0.71 ± 0.06 (range = 0.55–0.83), respectively. Mean scores
differed significantly in the repeated measures analysis (P < 0.0001), and the overall ICC
was 0.36. We also found evidence that BMI was differentially associated with the three
measures (P = 0.009), with differences in BMI having a greater effect on HUI3 than on
eQWB, and no effect on SF-6D. While the distributions of the SF-6D and eQWB were
approximately normal, the HUI3 was negatively skewed with some evidence of a ceiling
effect (3% of participants scored the maximum compared with 0% scoring the maximum for
the SF-6D and eQWB).
In multivariable analyses (Table 2), lower HUI3 scores were associated with higher BMI (P
= 0.003) and having undergone a hysterectomy (P = 0.018), but not with frequency of UI.
Scores on the SF-6D were lower among women reporting greater frequency of UI episodes
(P < 0.001) and monthly or greater fecal incontinence (P = 0.012) and higher among women
with greater physical activity (P for trend = 0.002). Lower eQWB scores were associated
with white race (P = 0.042), higher BMI (P < 0.001), and greater UI episode frequency (P =
0.015); higher eQWB scores were associated with greater physical activity (P for trend =
0.010). BMI accounted for a greater proportion of variance in eQWB score (η2 = 0.031)
compared with UI frequency (η2 = 0.016).
Discussion
In this study of overweight and obese women with urinary incontinence enrolled in a clinical
trial of a lifestyle weight loss intervention, mean HUI3, SF-6D, and SF-36-derived eQWB
scores were 0.81, 0.75, and 0.71, respectively. With an overall ICC of only 0.36, significant
differences in mean utility scores, and differential effects of BMI on the three measures, our
results indicate that these instruments do not assess identical dimensions of HRQL. Our
findings are consistent with previous reports documenting differences in mean values and
score distributions across preference-based HRQL measures [41, 49-55]. We found that the
eQWB produced the narrowest range of scores and the HUI3 produced the widest range,
although this may be related in part to differences in the upper and lower bounds of the
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scales. The eQWB and SF-6D yielded higher minimum scores (0.55 and 0.47, respectively)
compared with the HUI3 (lowest score = 0.08), which may suggest that these measures
overestimate poor health relative to the HUI3. Prior studies [29, 52] have noted that the
SF-6D may overpredict poor health states. Conversely, the HUI3 may underestimate poor
health relative to the SF-6D and eQWB. In addition to differences in scoring/valuation
methods across measures, variability in utilities obtained may also reflect differences in how
health is characterized using the HUI3 and SF-36 and how sensitive certain domains are to
the health effects associated with UI and obesity. As has been reported by others [49-51, 53,
54], significant variability in utility estimates across preference-based HRQL measures can
have a substantial impact on the outcome of CUAs. Thus, when choosing a measure to
obtain values to generate QALYs, researchers should consider whether the health domains
assessed by the instrument are reflective of and responsive to the specific health condition
being studied.
In multivariable models, higher BMI was the strongest independent correlate of lower
HRQL as reflected in both HUI3 and eQWB scores. In particular, among women with HUI3
scores near the sample mean of 0.81, decreases of just 1.3 kg/m2 in BMI predict increases
of .03 units in HUI3 score, which is a clinically important difference. In contrast, only a very
large decrease of 14 kg/m2 in BMI would predict a clinically meaningful increase of .03
units in average eQWB score. This reflects the statistically significant heterogeneity of the
BMI effects we found across the three outcome measures and illustrates the degree to which
choice of HRQL instrument can influence results. We also found that higher UI episode
frequency was independently associated with lower SF-6D and eQWB scores. However,
only very large decreases of 68 and 91% in UI episode frequency predict clinically
meaningful increases of 0.03 units in SF-6D and eQWB scores, respectively. Other
independent correlates of lower HRQL scores on at least one of the three measures in this
study included white race, hysterectomy, lower physical activity, and fecal incontinence.
The inverse relationships found between BMI and HUI3 and eQWB scores are consistent
with previous reports showing that increased BMI is associated with poorer HRQL [9, 22].
Lack of an association between BMI and SF-6D is in contrast to results of other studies that
report a significant relationship between BMI and SF-6D after controlling for demographic
variables and comorbid conditions. For example, a population study in Australia [56]
showed a significant negative association between BMI and SF-6D score among women
aged 18–79 years, and a large clinic-based study in the United Kingdom [18] reported lower
SF-6D scores among obese men and women compared with their normal-weight
counterparts. There are relatively few published studies of SF-6D scores in overweight and
obese samples or among women with incontinence, thus additional research is needed to
examine the sensitivity of this measure to decrements in HRQL associated with these
conditions.
The association between BMI and HUI3 in the current study suggests that the HUI3 is
sensitive to health effects of obesity and thus may be a useful tool to measure HRQL in
studies of obesity or weight loss. Certain HUI3 items such as those that address physical
pain and discomfort and walking ability may be more relevant to individuals who are obese.
On the other hand, our findings of a relationship between UI and SF-6D suggest that the
SF-6D may be more useful in studies of UI. This may be related to SF-36 items that address
social functioning, which perhaps is more relevant to individuals affected by UI. Since the
eQWB was the only score related to UI and obesity, investigations that include both
outcomes may benefit from computing this preference score from the SF-36. Further, it may
be informative for future studies to examine the usefulness of the self-administered version
of the QWB (QWB-SA) in this population given its broader range of values.
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Strengths of the current study include the observed measures of height and weight and
inclusion of three approaches to estimating preference-based HRQL. Limitations of this
study are that it is cross-sectional and thus no causal associations can be made and that it
includes only overweight and obese women with UI and therefore does not provide
information regarding the relation between BMI and HRQL for other populations. In
addition, since this study was a secondary analysis of baseline data from a randomized
controlled trial, it may not have been adequately powered to detect statistically significant
effects for all correlates of HRQL tested.
In this cohort of overweight and obese women with urinary incontinence, we found
significant differences in scores obtained from three preference-based measures of HRQL.
Both BMI and UI episode frequency were found to be related to HRQL; however, the
magnitude of the relationship depended on the measure used.
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Table 1
Characteristics of the participantsa
Total (N = 338)
Age (years) 53 ± 11
Race—no. (%)
 White 262 (77.5)
 Black 64 (18.9)
 Other 12 (3.6)
Education beyond high school—no. (%) 293 (86.7)
Relationship status—no. (%)
 Married or living with partner 256 (75.7)
 Single, widowed, or divorced 82 (24.3)
Annual household income—no./total no. (%)
 <$40,000 72/268 (26.9)
 $40,000–$99,9,999 142/268 (53.0)
 $100,000 or more 54/268 (20.1)
Body mass index (BMI; kg/m2) 36 ± 6
Diabetes—no. (%) 10 (3.0)
Current smoker—no. (%) 18 (5.3)
Current alcohol use—no. (%) 228 (67.5)
Post-menopausal—no./total no. (%) 177/316 (56.0)
Self-reported health status—no. (%)
 Excellent or very good 151 (44.7)
 Good 150 (44.4)
 Fair or poor 37 (10.9)
Hysterectomy—no./total no. (%) 99/337 (29.4)
Parity 2 ± 1
Type of urinary incontinence—no. (%)b
 Stress only/stress predominant 75 (22.2)
 Urge only/urge predominant 149 (44.1)
 Mixed 114 (33.7)
Urinary incontinence episodes per week 24 ± 18
24-h involuntary urine loss (g)c 33 ± 55
Monthly or greater fecal incontinence—no. (%) 35 (10.4)
a
Data are presented as mean ± standard deviation or number (percent)
b
Type of urinary incontinence was classified according to the participant’s designation of each incontinence episode in a 7-day voiding diary
c
Involuntary urine loss was measured by the 24-h increase in pad weight
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